GlassScriptPhysician profile
Barbara M Kuczynski
NPI 1912981234
$4,043.89
in general payments reported to CMS, 2019-2025
26 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $568 · 2020: $208 · 2021: $605 · 2022: $809 · 2023: $604 · 2024: $657 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,836 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,835.93 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $477.90 | 2022-2025 | Envista Mx60 Iol, Miebo, Ic-8 Apthera Iol |
| Kala Pharmaceuticals, INC. | $339.92 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $310.89 | 2019-2021 | |
| New World Medical,INC. | $277.01 | 2019-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Via360 |
| Alcon Vision LLC | $258.03 | 2019-2025 | Lensx, Clareon |
| Tarsus Pharmaceuticals, INC. | $228.49 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $220.51 | 2021-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $187.60 | 2020-2024 | Tecnis Iol, Catalys System |
| Dompe US, INC. | $186.37 | 2024-2025 | Oxervate |
| Rxsight INC | $163.21 | 2022-2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Handpiece |
| Allergan, INC. | $157.72 | 2021-2022 | |
| Shire North American Group INC | $150.10 | 2019 | |
| Sight Sciences, INC. | $149.72 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $123.96 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $119.32 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $111.69 | 2023 | Artevo 800 |
| Sun Pharmaceutical Industries INC. | $90.78 | 2019-2025 | |
| Abbvie INC. | $85.39 | 2022-2023 | |
| Rayner Intraocular Lenses Limited | $80.36 | 2022-2024 | Rayone Aspheric, Rayone Emv, Omidria |
| Johnson & Johnson Vision Care, INC. | $76.50 | 2019-2025 | |
| Ocular Therapeutix, INC. | $68.52 | 2023-2025 | Dextenza |
| Amgen INC. | $49.80 | 2024 | Tepezza |
| Oyster Point Pharma, INC. | $47.30 | 2023-2024 | Tyrvaya |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $35.31 | 2024 | |
| Harrow Eye, LLC | $30.47 | 2025 | Iheezo |
| Omeros Corporation | $17.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Kuczynski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.